[e-drug] MedIC Course in Pharmaceutical Policy Analysis - Date Change

E-DRUG: MedIC Course in Pharmaceutical Policy Analysis - Date Change
-----------------------------------------------------------

The dates for this course have changed and a limited number of scholarships are now available.

   The WHO Collaborating Center in Pharmaceutical Policy, Boston, USA;
   Ateneo de Manila University; and the Philippine Health Insurance
   Corporation, Manila, Philippines announce the
   Medicines and Insurance Coverage (MedIC) Initiative
   Course in Pharmaceutical Policy Analysis
   at the Ateneo Professional Schools, Ateneo de Manila University,
   Rockwell Center, Makati City, Philippines
   September 23 through 29, 2007
    ** PLEASE NOTE CHANGE IN COURSE DATES **

   Background
   Medicines coverage through health insurance programs can be a
   scaleable and sustainable means to improve access to and use of
   medicines. Evidence-based medicines policy decision making is
   required to achieve maximum benefits at affordable costs. We are
   offering a unique 6-day course in medicines policy analysis.
   The course is primarily intended for policy makers, analysts,
   actuaries, and others involved in making medicines benefit decisions
   for health insurance programs in Asia. We especially seek teams of
   3-5 participants from individual health insurance programs committed
   to active policy assessment and implementation after the course.
   Others interested in pharmaceutical policy issues in health systems
   may also benefit from the course. To allow for effective group work,
   the maximum number of participants will be 40.
   
Objectives
   Participants will enhance skills to identify problems in medicines
   access and use, and to design, implement, and evaluate medicines
   benefit policies in health insurance systems.

Design
   This highly interactive course will consist of small and large group
   case discussions and small group hands-on analyses of health insurance
   program data. During the course, participants will focus on a
   specific medicines policy issue relevant to their system, and develop
   a post-course plan to design and implement a policy intervention to
   improve key outcomes. The course language is English.

   Selected Topics
   Participants and facilitators will address a broad range of questions
   that arise when making evidence-based medicines policy decisions,
   including:
   · Why extend coverage for medicines in health insurance programs?
   · Which groups of enrollees benefit the most from expanded medicines coverage?
   · What are the advantages and disadvantages of specific medicines policies?
   · What is the best way to design, implement, and manage a formulary?
   · How can routine medicines data be used to develop evidence-based policies?
   · How can insurance programs evaluate changes in medicines coverage?
   · What are the best measures for routine monitoring of medicines policies?

   Course Facilitators
   The course will be led by a team of experienced facilitators who have
   worked for two decades on improving use of medicines and who are
   actively involved in evaluating medicines coverage policies in
   developed and developing countries. Facilitators will include Drs.
   Anita Wagner and Dennis Ross-Degnan (http://dacp.org/facult) Harvard Medical School and Harvard Pilgrim Health Care; Drs. Marife
   Yap, John Wong, and Kenneth Hartigan-Go from the Health Unit, Graduate
   School of Business, Ateneo de Manila University; Dr. Madeleine Valera
   from the Philippine Health Insurance Corporation; Dr. Richard Laing
   from WHO/Geneva; and Dr. John Chalker, Coordinator of the
   International Network for the Rational Use of Drugs (INRUD).

   Local Course Director:
   Maria Eufemia Yap, MD, MSc
   Health Unit, Ateneo Graduate School of Business
   Ateneo Professional Schools
   Phone: +61 (0)2 899 7692 local 2209 to 2211
   E-mail: meyap@aps.ateneo.edu or marife_yap@yahoo.com
   International Course Director:
   Anita Wagner, PharmD, MPH, DrPH
   Department of Ambulatory Care and Prevention
   Harvard Medical School & Harvard Pilgrim Health Care
   Phone: +1 617 509 9956
   E-mail: awagner@hms.harvard.edu

   Tuition
   The tuition for the course is US $1500.00. Tuition covers the 6-day
   workshop, training materials, computer use, lunch and refreshments
   during the course, a welcome reception and a welcome dinner.
   Participants are responsible for covering the costs of travel,
   accommodation, breakfast and dinner (except for the welcome dinner),
   and incidentals. A limited number of scholarships are available.

   Logistics
   The course begins in the afternoon of Sunday, September 23, 2007 with
   registration and a welcome reception. Participants from insurance
   programs will be requested to complete a questionnaire about their
   programs prior to the course. The course ends in the evening of
   Saturday, September 29, 2007.
   Participants need to make their own travel arrangements and book their
   accommodations. Recommendations for hotels near the course facilities
   with special rates can be obtained when registering for the course.

   Registration and Payment
   Completed registration forms and payments by applicants or sponsors
   need to be received via mail, fax, or e-mail by Friday, August 31,
   2007. Space will be limited and participants are encouraged to apply
   early.
   For registration form, suggestions for hotels:
   Ms. Khrisna Reyes, Health Unit, Ateneo Graduate School of Business,
   Makati City, Philippines; Phone: +63 (0)2 899 7691 local 2211; Fax:
   +63 (0)2 899 4589; E-mail: khrisnareyes@yahoo.com and
   kreyes@aps.ateneo.edu
   For registration form, tuition payment, information about scholarships:
   Ms. Joyce Cheatham, Department of Ambulatory Care and Prevention,
   Harvard Phone: +1 617 [8]joyce_cheatham@hphc.org.